- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00797654
HIV Prevention and Trauma Treatment in Men Who Have Sex With Men and Who Have a History of Sexual Abuse
Integrated HIV Prevention and Trauma Treatment in MSM With Sexual Abuse History (Project THRIVE)
Study Overview
Status
Conditions
Detailed Description
Men who have sex with men (MSM) represent the largest group of new HIV infections. Rates of childhood sexual abuse (CSA) in MSM have been estimated to be higher than in the rest of the population, with some researchers estimating that 37% of all MSM have experienced CSA. CSA in MSM is associated with both higher rates of HIV risk behavior and higher rates of HIV infection. Treatments for preventing HIV are also less likely to be effective in MSM with a history of CSA, and these individuals tend to have higher rates of depression, anxiety, substance abuse, and post-traumatic stress disorder (PTSD) symptoms. This study will create and then test a new HIV prevention therapy that addresses both HIV risk behaviors and the co-occurring psychological health problems in MSM with a history of CSA.
This study includes a pilot phase and an experimental phase. In the pilot phase, the therapeutic treatment will be developed based on elements of successful interventions for reducing sexual risk-taking behaviors and PTSD symptoms. Information-motivation-behavioral (IMB) skills training for sexual risk reduction will be the basis for one of two treatment components, and it is expected to last for two 50-minute sessions. This intervention will include addressing knowledge about issues surrounding sexual risk, using motivational interviewing to address goals and self-efficacy, and providing strategies for behavioral change. Cognitive processing therapy (CPT) for CSA will be the basis for the other component and is expected to last for eight 50-minute sessions. Elements of this intervention will include identifying sexual abuse events, learning how to identify cognitive distortions, and learning processes to challenge and process these distortions.
During the pilot phase, approximately 10 participants will undergo the new treatment. After completing the treatment sessions, participants will undergo exit interviews, in which researchers will solicit feedback about the strengths and weaknesses of the treatment. This feedback will be used to fine tune the treatment.
During the second phase of the study, approximately 50 individuals will be randomly assigned to receive either HIV testing with pre/post-test counseling alone or in combination with the newly developed treatment. The experimental, integrated treatment will be administered over 10 individual therapy sessions comprised of sexual risk reduction counseling and cognitive therapy.
All participants will undergo assessments at enrollment and after treatment (or approximately 3 months after enrollment in comparator group), and at follow-up visits 6 and 9 months after enrollment. These assessments will measure sexual risk behaviors, PTSD symptoms, distress, social support, and substance abuse. Brief questionnaires about sexual behavior and measures of distress will be administered during the integrated treatment sessions.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Fenway Community Health
-
Boston, Massachusetts, United States, 02215
- Fenway Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Identifies as a biological man who has sex with men
- Reports history of childhood sexual abuse (sexual contact before the age of 13 with an adult or person 5 years older or sexual contact with the threat of force or harm between the ages of 13 and 16, inclusive, with a person 10 years older)
- Reports unprotected anal or vaginal intercourse within the past 3 months
- HIV-negative serostatus
- Able to understand English
Exclusion Criteria:
- All episodes of unprotected anal or vaginal intercourse occurred with only a single, primary HIV-negative partner
- Significant mental health diagnosis requiring immediate treatment, such as acute major depression, panic disorder, or any psychotic disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
Participants will receive pre and post HIV-test counseling and an information-motivation-behavior skills training combined with cognitive processing therapy
|
Treatment will include elements from effective interventions for reducing risky sexual behaviors and reducing post-traumatic stress disorder (PTSD) symptoms.
Treatments are aimed at assessing and reducing behaviors that put participants at high risk of HIV infection.
|
|
Active Comparator: 2
Participants will receive pre and post HIV-test counseling
|
Treatments are aimed at assessing and reducing behaviors that put participants at high risk of HIV infection.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported sexual risk taking
Time Frame: Measured pre- and post-treatment and after 6 and 9 months
|
For both the Treatment (Cognitive Processing Therapy with Information Motivation Behavior) and Control arms, participants will self-report sexual risk taking at baseline, 3-month post baseline, and at 6 and 9-month follow-ups (after enrollment).
|
Measured pre- and post-treatment and after 6 and 9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reductions in negative effects of trauma, with cognitive and behavioral variables tested as potential mediators of treatment outcome
Time Frame: Measured pre- and post-treatment and after 6 and 9 months
|
As with the baseline assessment, the Davidson Post-Traumatic Stress Disorder scale, and the MINI Neuro-psychiatric Interview for PTSD will be administered by an Independent Assessor who will be blind to participant group assignment.
|
Measured pre- and post-treatment and after 6 and 9 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Conall M. O'Cleirigh, PhD, Fenway Community Health
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- R34MH081760-02 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Risk Reduction
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsCompletedRisk ReductionSouth Africa
-
University of California, San FranciscoUniversity of MiamiCompletedRisk ReductionUnited States
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsCompleted
-
Charite University, Berlin, GermanyRecruitingAnesthesiological Risk Reduction | Intensive Care Risk ReductionGermany
-
Colorado State UniversityUniversity of Colorado, Denver; United States Department of Agriculture (USDA) and other collaboratorsRecruitingMental Health Wellness | Lifestyle Risk Reduction | Family ResearchUnited States
-
Istituto per la Ricerca e l'Innovazione BiomedicaFondazione Don Carlo Gnocchi Onlus; Universita degli Studi di Palermo; Medilink...RecruitingHealth Promotion | Life Style, Healthy | Risk ReductionItaly
-
National Taiwan University HospitalCompletedLifestyle Risk Reduction | Elderly Adults | Community DwellingTaiwan
-
University of California, San FranciscoUniversity of California, Berkeley; National Institute of Environmental Health... and other collaboratorsCompletedRisk Reduction | Children, Only | Environmental ExposureUnited States
-
Stanford UniversityWithdrawnRisk ReductionUnited States
-
University of Maryland, BaltimoreCompleted
Clinical Trials on Information-motivation-behavior skills and cognitive processing therapy
-
VA Office of Research and DevelopmentCompletedMajor Depressive Disorder | Posttraumatic Stress Disorder | Panic Disorder and AgoraphobiaUnited States
-
Northwestern UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedQuality of Life | Inflammation | Sleep Disturbance | Bereavement | SpousesUnited States
-
United States Department of DefenseMayo Clinic; Baylor College of Medicine; Minneapolis Veterans Affairs Medical... and other collaboratorsRecruitingPost Traumatic Stress DisorderUnited States
-
Dr. Veronica TettertonNational Institute on Minority Health and Health Disparities (NIMHD)CompletedAnxiety DepressionUnited States
-
University of North Carolina, CharlotteOhio State University; United States Naval Medical Center, PortsmouthActive, not recruitingDepression | PTSD | Anxiety | Suicidal Ideation | Suicide, Attempted | Coping SkillsUnited States
-
Medstar Health Research InstituteNational Cancer Institute (NCI)Not yet recruiting
-
University of North Texas, Denton, TXDuke University; The University of Texas Health Science Center at San Antonio; Boston VA Research Institute, Inc... and other collaboratorsUnknownInsomnia | Trauma | NightmaresUnited States
-
Baylor College of MedicinePatient-Centered Outcomes Research InstituteCompleted
-
The University of Hong KongRecruitingBPSD (Behavioral and Psycological Symptoms of Dementia) | Expressed Emotion | Depressive Symptom | Caregiving StressHong Kong
-
University Hospital, BordeauxCentre National de la Recherche Scientifique, FranceTerminatedObesity | Addiction | Craving | Cognitive Behavioral Therapy | Cognitive Remediation TherapyFrance